Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice by Shimoda, Hiroshi et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Complementary and 
Alternative Medicine
Open Access Research article
Inhibitory effect of green coffee bean extract on fat accumulation 
and body weight gain in mice
Hiroshi Shimoda*, Emi Seki and Michio Aitani
Address: Oryza Oil & Fat Chemical Co., Ltd., Research & Development Division, 1 Numata Kitagata-cho, Ichinomiya, Aichi 493-8001, Japan
Email: Hiroshi Shimoda* - kaihatsu@mri.biglobe.ne.jp; Emi Seki - kaihatsu@mri.biglobe.ne.jp; Michio Aitani - kaihatsu@mri.biglobe.ne.jp
* Corresponding author    
Abstract
Background: An epidemiological study conducted in Italy indicated that coffee has the greatest
antioxidant capacity among the commonly consumed beverages. Green coffee bean is rich in
chlorogenic acid and its related compounds. The effect of green coffee bean extract (GCBE) on fat
accumulation and body weight in mice was assessed with the objective of investigating the effect of
GCBE on mild obesity.
Methods: Male ddy mice were fed a standard diet containing GCBE and its principal constituents,
namely, caffeine and chlorogenic acid, for 14 days. Further, hepatic triglyceride (TG) level was also
investigated after consecutive administration (13 days) of GCBE and its constituents. To examine
the effect of GCBE and its constituents on fat absorption, serum TG changes were evaluated in
olive oil-loaded mice. In addition, to investigate the effect on hepatic TG metabolism, carnitine
palmitoyltransferase (CPT) activity in mice was evaluated after consecutive ingestion (6 days) of
GCBE and its constituents (caffeine, chlorogenic acid, neochlorogenic acid and feruloylquinic acid
mixture).
Results: It was found that 0.5% and 1% GCBE reduced visceral fat content and body weight.
Caffeine and chlorogenic acid showed a tendency to reduce visceral fat and body weight. Oral
administration of GCBE (100 and 200 mg/kg· day) for 13 days showed a tendency to reduce hepatic
TG in mice. In the same model, chlorogenic acid (60 mg/kg· day) reduced hepatic TG level. In mice
loaded with olive oil (5 mL/kg), GCBE (200 and 400 mg/kg) and caffeine (20 and 40 mg/kg) reduced
serum TG level. GCBE (1%), neochlorogenic acid (0.028% and 0.055%) and feruloylquinic acid
mixture (0.081%) significantly enhanced hepatic CPT activity in mice. However, neither caffeine nor
chlorogenic acid alone was found to enhance CPT activity.
Conclusion: These results suggest that GCBE is possibly effective against weight gain and fat
accumulation by inhibition of fat absorption and activation of fat metabolism in the liver. Caffeine
was found to be a suppressor of fat absorption, while chlorogenic acid was found to be partially
involved in the suppressive effect of GCBE that resulted in the reduction of hepatic TG level.
Phenolic compounds such as neochlorogenic acid and feruloylquinic acid mixture, except
chlorogenic acid, can enhance hepatic CPT activity.
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Background
Coffee is one of the most commonly consumed beverages
worldwide. However, the stimulating effect of caffeine on
the central nervous system has significantly reduced the
frequency of consumption due to its side effects on the
cardiovascular system [1], central nervous system [2], and
endocrine system [3]. On the other hand, scientific studies
have revealed that both coffee and caffeine play a preven-
tive role against various degenerative diseases of modern
society. Van Dam and Feskens [4] reported that moderate
daily consumption of coffee helped to reduce the risk of
type 2 diabetes, while Fredholm and Lindgren found that
caffeine promotes lipolysis in rat adipocytes [5]. Human
studies show that caffeine enhances energy expenditure
[6] and improves the clinical conditions of diabetic
patients [7,8]. Another study by Greer et al. revealed that
caffeine ingestion promotes glucose consumption with an
increase in blood epinephrine [9], while pre-exercise con-
sumption promotes ventilation and enhances lipolysis
[10]. Chlorogenic acid, another main constituent of coffee
beans, has recently been reported to selectively inhibit
hepatic glucose-6-phosphatase [11], which is a rate-limit-
ing enzyme involved in gluconeogenesis. However, roast-
ing of coffee beans has been shown to reduce the content
of chlorogenic acid in coffee [12]. Green coffee beans are
rich in chlorogenic acid and its related compounds that
show hypotensive effect [13]. In the present study, the
effect of green coffee bean extract (GCBE) and its principal
constituents on mice body weight and visceral fat contents
were investigated. In addition, the effect of GCBE on fat
absorption and metabolism were examined.
Methods
Animals
Male ddy mice (Japan SLC Inc., Shizuoka, Japan) were
used for the experiments. The animals were housed at
23°C ± 1°C and were fed standard non-purified diet (CE-
2, Clea Japan Inc., Shizuoka, Japan) and tap water ad libi-
tum. The experiments were conducted in accordance with
the Guidelines for Animal Experimentation (Japan Asso-
ciation for Laboratory Animal Science, 1987). All experi-
mental designs were approved by the Ethical Committee
for Use of Experimental Animals.
Preparation and determination of GCBE
GCBE (yield: 13.7%) was extracted from green coffee (cof-
fea canephora) beans at 70°C for 2 h using 70% ethanol.
Caffeine, chlorogenic acid and its related compounds
were analysed by HPLC using anhydrous caffeine (Kishida
Chemical Co., Ltd., Osaka, Japan) and chlorogenic acid
(Sigma-Aldrich Co., Ltd., St. Louis, MO, USA) as stand-
ards (Figure 1). HPLC equipped with a Capcellpack C18
(4.6 φ × 250 mm, Shiseido, Tokyo, Japan) and a photodi-
ode array detector (SPD-10 Avp, Shimadzu, Kyoto, Japan)
was used. The solvent used included (A) 2 mM H3PO4 and
(B) CH3CN; a linear gradient of (A) was changed to (B)
after 35 min. The flow rate was maintained at 1.0 mL/min.
The amounts of caffeine and chlorogenic acid detected
were 10.0% and 27.0%. As shown in Figure 2, GCBE con-
tains chlorogenic acid and other related compounds,
namely, 3-caffeoylquinic acid (neochlorogenic acid) and
a mixture of feruloylquinic acids. These compounds were
isolated and identified from GCBE [14]. The amounts of
3-caffeoylquinic acid and a mixture of feruloylquinic
acids using standard chlorogenic acid were 5.5% and
16.0%. The content of 4,5-dicaffeoylquinic acid was 5.2%
using an authentic sample which was isolated from Japa-
nese butterbur.
Reagents
Sesamin (Industrial Research, Ltd., Wellington, New Zea-
land) and orlistat (Hoffman-La Roche Ltd., Basel, Switzer-
land) were used as reference compounds. EDTA was
purchased from Kishida Chemical Co., Ltd. (Osaka,
Japan), while palmitoyl CoA and L-carnitine were
obtained from Sigma-Aldrich Co., Ltd. (MA, USA). Cal-
cium and magnesium-free phosphate buffered saline [PBS
(-)], Triglyceride E-test Wako, olive oil, sucrose, Triton X-
100 and 5,5'-dithiobis(2-nitrobenzoate) (DTNB) were
purchased from Wako Pure Chemicals Industries, Ltd.,
Osaka, Japan.
Measurements of mice body weight and visceral fats
Six week-old mice were given free access to nonpurified
diet (CE-2) containing 0.5% or 1% GCBE for 14 days. Caf-
feine (0.05% and 0.1%) and chlorogenic acid (0.15% and
0.3%) were added to the diet. Mice were weighed every 2
days. Mice epididymal and perirenal fats were removed
and weighed at the end of the experiment. Orlistat, a med-
icine prescribed for obesity, was used as a positive control.
Measurements of hepatic triglyceride level in mice
Acacia gum (5%) suspension containing GCBE (100 and
200 mg/kg· day), caffeine (10 and 20 mg/kg· day) and
chlorogenic acid (30 and 60 mg/kg· day) was adminis-
tered daily to 5 week-old mice for 13 days. On day 14, the
livers were removed and approximately 200 mg of the
liver was homogenized in 1 mL of PBS (-). This suspen-
sion was then centrifuged (2200 × g, 10 min), followed by
the extraction of hepatic triglyceride (TG) using a mixture
of chloroform and methanol (2:1). The extract was evap-
orated and resuspended in 1 mL PBS (-). The TG content
was measured using Triglyceride E-test Wako. Sesamin
was used as a positive control.
Determination of serum TG in olive oil-loaded mice
The experiments were carried out as described by Shi-
moda et al. [15]. Initial blood samples were collected from
infraorbital venous plexus of mice (aged 5 to 6 weeks)
after fasting for 20–22 h. The mice were administered withBMC Complementary and Alternative Medicine 2006, 6:9 http://www.biomedcentral.com/1472-6882/6/9
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an acacia gum (5%) suspension containing GCBE (200
and 400 mg/kg), caffeine (20 and 40 mg/kg) and chloro-
genic acid (60 and 120 mg/kg). After 30 min, olive oil (5
mL/kg) was administered to the mice. Blood samples were
collected at intervals of 2 h after loading with olive oil.
The samples were centrifuged and serum TG was meas-
ured using Triglyceride E-test Wako. Orlistat was used as a
positive control.
Measurements of hepatic carnitine palmitoyltransferase 
activity in mice
Six week-old mice were fed a diet (CE-2) containing GCBE
(0.5% and 1%), caffeine (0.05% and 0.1%), chlorogenic
acid (0.15% and 0.3%), neochlorogenic acid (0.028%
and 0.055%) and a mixture of feruloylquinic acids
(0.081%) for 6 days. Mice livers were removed and
homogenized in Tris-HCl buffer (pH 7.4) weighing 6-
fold that of liver weight containing 0.25 M sucrose and 1
mM EDTA. The homogenate was centrifuged (880 × g,
4°C, 10 min) and the supernatant was collected; this was
followed by a second centrifugation (11,770 × g, 4°C) to
obtain mitochondrial fraction. The precipitate of the
mitochondrial fraction was flushed and suspended in
buffer to obtain a protein concentration of 6 mg/mL. CPT
activity was measured according to the method described
by Markwell et al. [16]. Tris buffer (58 mM, pH 8.0, 1 mL)
containing 1.25 mM EDTA, 0.1% Triton X-100 and 0.25
mM DTNB, 37.5 μM palmitoyl CoA (20 μL) and 6 mg/mL
mitochondrial fraction (20 μL) were mixed, and the opti-
cal density (OD) was recorded at 412 nm for 5 min. Sub-
sequently, 1.25 mM L-carnitine (20 μL) was added, and
the OD was recorded for 5 min. The CPT activity was cal-
culated as follows:
ΔODa: Linearity of optical density change for 1 min after
addition of L-carnitine solution
ΔODb: Linearity of optical density change for 1 min at
baseline
c: Volume of mitochondrial fraction (μL)
d: Molar extinction coefficient of palmitoyl-CoA
e: Protein contents in mitochondrial fraction (mg protein/
mL)
CPT activity nmol min mg protein
OD OD ab c
(/ / )
() ,
=
−× × ΔΔ 20 10 000
13, ,000 6 de ×
Three dimensional HPLC chromatogram of GCBE Figure 1
Three dimensional HPLC chromatogram of GCBE.BMC Complementary and Alternative Medicine 2006, 6:9 http://www.biomedcentral.com/1472-6882/6/9
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Statistics
The results were expressed as mean ± SE. Significance of
the differences was examined using the one-way ANOVA
method, followed by Dunnett's test. Results with p < 0.05
were considered significant.
Results
Effect on body weight and visceral fat accumulation in 
mice
The changes in mice body weight and visceral fat content
during the 14-day treatment with GCBE are tabulated in
Table 1. The amount of diet intake was not reduced during
the GCBE treatment. GCBE (0.5% and 1%) significantly
suppressed mice body weight. The weight of mice epididy-
mal and perirenal fats was significantly reduced in the
group treated with GCBE (0.5%). However, the results for
the effect of caffeine (0.05% and 0.1%) on the suppres-
sion of body weight and visceral fat were not significant.
Chlorogenic acid (0.15% and 0.3%) demonstrated a weak
suppressive effect on body weight and perirenal fat accu-
mulation. Orlistat (0.1%), the positive control, showed a
slight suppressive effect on epididymal and perirenal fat
accumulation but no suppressive effect on body weight.
Effect on hepatic TG accumulation in mice
The hepatic TG levels in mice were reduced after a 13-day
treatment with GCBE, caffeine and chlorogenic acid. Fig-
ure 3 illustrates the effect of GCBE, caffeine and chloro-
Chemical structures of constituents of GCBE Figure 2
Chemical structures of constituents of GCBE.
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genic acid on hepatic TG. GCBE and caffeine showed a
tendency to suppress hepatic TG. Further, the level of
hepatic TG was significantly reduced by chlorogenic acid
(60 mg/kg· day), suggesting its role in the suppression of
hepatic TG in the group treated with GCBE.
Effect on elevated serum TG level in olive oil-loaded mice
The effects of GCBE and its constituents on fat absorption
were examined in olive oil -loaded mice. The level of
serum TG after fasting for 22 h was 60 to 125 mg/dL. The
results showed that the elevated serum TG level was signif-
icantly lowered in groups treated with GCBE (200 and
400 mg/kg) as illustrated in Figure 4. Similarly, caffeine
(20 and 40 mg/kg) also showed a suppressive effect on the
increase in serum TG levels. However, chlorogenic acid at
concentrations of 60 and 120 mg/kg did not affect serum
TG levels. Caffeine is suggested to be the contributing
compound for the suppression of fat absorption in GCBE-
treated mice. Elevated serum TG level was completely sup-
pressed by orlistat (60 mg/kg).
Effect on hepatic CPT activity in mice
Part of the fatty acid metabolized and released from the
adipose tissue is transferred to the liver for the oxidation
process in the mitochondria of hepatocytes. CPT is a rate-
limiting enzyme that catalyses the transportation of fatty
acid to mitochondria for β-oxidation. As shown in Figure
5, GCBE (0.5% and 1%) demonstrated a dose-dependent
enhancement of CPT activity in the liver mitochondria.
Neochlorogenic acid (0.028% and 0.055%) and feruloyl-
quinic acid mixture (0.081%) significantly enhanced CPT
activity. However, caffeine and chlorogenic acid had no
effect on CPT activity in the liver mitochondria. Sesamin
(0.1%), the positive control, slightly enhanced the CPT
activity.
Discussion
The results showed that consumption of GCBE for 14 days
caused a suppressive effect on weight gain and visceral fat
accumulation in mice. GCBE contains 10% caffeine and
27% chlorogenic acid as the principal constituents, and
these constituents showed a tendency to suppress body
weight gain and visceral fat accumulation. Thus, these
constituents are suggested to be partially involved in the
suppressive effect of GCBE on body weight gain and vis-
ceral fat accumulation. Caffeine is known to be a lipolytic
compound. On the other hand, the effect of chlorogenic
acid on body weight gain has not yet been established.
Rodriguez de Sotillo and Hadley reported that serum and
hepatic TG levels were lowered with intravenous adminis-
tration of chlorogenic acid in Zucker fa/fa rats [17]. How-
ever, the TG level in the adipose tissue was not lowered.
Table 1: Effects of GCBE and its constituents on body weight gain and accumulation of visceral fats
Content in diet (%) Mean total food intake (g/
body)
Initial body weight Day 0 
(g)
Final body weight Day 14 
(g)
Control -- 75.3 28.2 ± 0.6 37.5 ± 1.6
GCBE 0.5 80.0 27.3 ± 0.5 33.2 ± 0.6 *
1 75.5 26.9 ± 0.7 32.8 ± 1.2 **
Caffeine 0.05 74.9 27.0 ± 0.4 35.0 ± 1.0
0.1 74.3 26.6 ± 0.4 33.9 ± 0.7
Chlorogenic acid 0.15 81.3 27.3 ± 0.5 35.2 ± 0.5
0.3 76.5 26.4 ± 0.3 34.5 ± 0.5
Control -- 73.8 26.8 ± 0.4 34.6 ± 1.2
Orlistat 0.05 82.4 27.0 ± 0.2 35.0 ± 0.4
0.1 81.3 26.3 ± 0.2 34.2 ± 1.0
Content in diet (%) Body weight gain (g) Epididymal fat (mg) Perirenal fat (mg)
Control -- 9.3 ± 0.4 605 ± 71 223 ± 39
GCBE 0.5 6.0 ± 0.1 * 393 ± 59* 106 ± 20 *
1 5.8 ± 0.2 * 448 ± 68 124 ± 23
Caffeine 0.05 8.0 ± 0.2 536 ± 57 146 ± 29
0.1 7.3 ± 0.2 491 ± 39 150 ± 20
Chlorogenic acid 0.15 7.9 ± 0.1 574 ± 48 173 ± 24
0.3 8.1 ± 0.1 605 ± 82 175 ± 25
Control -- 7.8 ± 0.9 588 ± 55 249 ± 60
Orlistat 0.05 8.1 ± 0.4 612 ± 56 251 ± 45
0.1 7.8 ± 0.9 481 ± 51 * 180 ± 33 *
Mice were fed non-purified diet (CE-2) containing each sample for 14 days. Each value represents the mean ± SE of 6 to 7 mice. The asterisks 
denote a significant differences from the control group, *:p < 0.05 and **: p < 0.01.BMC Complementary and Alternative Medicine 2006, 6:9 http://www.biomedcentral.com/1472-6882/6/9
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Therefore, chlorogenic acid is suspected to be effective on
hepatic TG, and not adipose TG. In our study, both pure
caffeine and chlorogenic acid alone did not significantly
suppress weight gain or visceral fat accumulation.
Recently, it was demonstrated that catechin and caffeine
in green tea showed synergistic effects on enhancing fat
expenditure in obese mice [18]. Chlorogenic acid is also a
dietary polyphenolic compound with antioxidative activ-
ity. Thus, it is suggested that caffeine, chlorogenic acid and
other polyphenolic compounds in GCBE act synergisti-
cally to suppress body weight gain and visceral fat accu-
mulation in mice.
Additional experiments were conducted to examine the
effect of GCBE and chlorogenic acid on hepatic TG accu-
mulation. Oral administration of chlorogenic acid (30
and 60 mg/kg· day) for 14 days reduced the level of
hepatic TG in mice. However, the amount of visceral fat
was unchanged (data not shown). The suppressive effect
of chlorogenic acid on hepatic TG accumulation was more
potent than that of GCBE. This result suggests that the TG-
lowering effect of GCBE is partially due to chlorogenic
acid. The other constituents of GCBE, such as cafestol and
kahweol, which promote synthesis of lipids [19], may
cause discrepancy in the activities of GCBE (crude chloro-
genic acid) and pure chlorogenic acid.
Further studies were prompted to examine the anti-obes-
ity effect of GCBE on dietary fat absorption using olive oil-
loaded mice. The elevated serum TG level was lowered by
GCBE and caffeine in olive oil-loaded mice. Coffee has
been reported to delay gastric emptying [20]via constric-
tion of smooth muscles in the proximal stomach. Hence,
Effects of GCBE, caffeine, chlorogenic acid and sesamin on hepatic TG accumulation in mice Figure 3
Effects of GCBE, caffeine, chlorogenic acid and sesamin on hepatic TG accumulation in mice. Each sample was 
administered once a day for 13 days. The columns represent the mean ± SE of 7 mice. The double asterisks denote a significant 
difference from the control group, **: p < 0.01.BMC Complementary and Alternative Medicine 2006, 6:9 http://www.biomedcentral.com/1472-6882/6/9
Page 7 of 9
(page number not for citation purposes)
Inhibitory effects of GCBE, caffeine, chlorogenic acid and orlistat on serum TG elevation in olive oil-loaded mice Figure 4
Inhibitory effects of GCBE, caffeine, chlorogenic acid and orlistat on serum TG elevation in olive oil-loaded 
mice. An initial blood sample was collected from each mouse, and each sample was orally administered 30 min later. After 1 h, 
olive oil was orally administered and a blood sample was collected every 2 h. Symbols represent the mean ± SE of 6 mice. The 
double asterisks denote a significant difference from the control group, **: p < 0.01.BMC Complementary and Alternative Medicine 2006, 6:9 http://www.biomedcentral.com/1472-6882/6/9
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caffeine is suggested to delay fat absorption leading to
lowering of elevated serum TG level.
Finally, the effect of GCBE and its constituents on hepatic
CPT activity was examined. CPT activity was enhanced
after 6-day consumption of GCBE. However, no effect was
observed when similar examinations were conducted
using caffeine and chlorogenic acid alone. Other polyphe-
nolic compounds, namely, neochlorogenic acid and feru-
loylquinic acid, were isolated, and their effects on CPT
activity were assessed. The chemical structures of neochlo-
rogenic acid and feruloylquinic acid are quite similar to
chlorogenic acid. The stereo configuration of carboxylic
acid and caffeic acid or ferulic acid conjugated to the
quinic acid moiety are suggested to be involved in the
expression of the activity. Although the latest findings
have revealed that sesamin [21] and γ-linoleic acid [22]
enhance CPT gene expression, only a few reports have
described the effects of dietary polyphenolic compounds.
Moreover, their structure-activity relationship with regard
to CPT activity has not been established. Further studies
are required to determine the CPT enhancing activity of
chlorogenic acid and its related compounds in GCBE.
Effects of GCBE, its constituents and sesamin on hepatic CPT activity in mice Figure 5
Effects of GCBE, its constituents and sesamin on hepatic CPT activity in mice. Mice were allowed free access to a 
diet containing each sample for 6 days. The CPT activity in the liver mitochondrial fraction was measured by the DTNB 
method. The columns represent the mean ± SE of 4–5 mice. The asterisks denote a significant difference from the control 
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Conclusion
We conclude that GCBE can suppress body weight gain
and visceral fat accumulation in mice. Caffeine suppresses
fat absorption, while chlorogenic acid and its related com-
pounds are found to be involved in the enhancement of
fat metabolism in the liver.
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